Sk Life Science, Inc.

This study tests a medicine called cenobamate in 140 children aged 2 to 17 who have partial-onset (focal) seizures. The goal is to see if the drug is safe and helps control seizures. Children will take the medicine and be monitored for side effects and how well it works. This is …

This study tests cenobamate, an approved seizure drug, when used by itself in adults with partial-onset epilepsy. About 49 participants will take either 100 mg or 200 mg daily to see if they become seizure-free for 26 weeks. The goal is to gather more data on how well cenobamate …

This study looks at the long-term safety of the drug cenobamate for people with a type of seizure called primary generalized tonic-clonic seizures. About 145 adults who finished a previous study will take cenobamate for one year. Researchers will track side effects and overall he…